Osaka University researchers elucidated the pathophysiology of systemic lupus erythematosus (SLE), an autoimmune disorder that causes inflammation and tissue damage. Their study used patient ...

Osaka University researchers elucidated the pathophysiology of systemic lupus erythematosus (SLE), an autoimmune disorder that causes inflammation and tissue damage. Their study used patient ...

There are currently 146 products in active development for Systemic Lupus Erythematosus (SLE). Around half of the pipelines are in early stage development, with 74 products in the discovery and ...

1.2 List of Figures 2 SLE & LN: Executive Summary 2.1 SLE and LN Marketplace to Experience Strong Growth During the Forecast Period, 2018-2028 2.2 R&D or Corporate Strategies for the Lupus Market ...

Nephritis, clinical trials and biomarkers rank highest among research priorities related to childhood-onset systematic lupus erythematosus, according to a survey of rheumatologists, dermatologists ...

Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." What causes SLE? Experts ...

A subset of lupus autoantibodies can penetrate nuclei and damage DNA in cells, with consequences for the pathophysiology of systemic lupus erythematosus as well as cancer risk. Noble et al ...

Analyses were stratified by baseline SLE Disease Activity Index scores, classified as mild, moderate, or severe, and by diagnosis year, grouped into four periods: 2001-2005, 2006-2010, 2011-2015 ...